| Bioactivity | Cap-dependent endonuclease-IN-21 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-21 inhibits the replication of influenza virus. ap-dependent endonuclease-IN-21 has the potential for the research of influenza virus infection (influenza A) (extracted from patent WO2021233302A1, compound 8B or 8A)[1]. |
| Name | Cap-dependent endonuclease-IN-21 |
| CAS | 2741952-35-0 |
| Formula | C26H23F2N3O7 |
| Molar Mass | 527.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shuhui Chen, et al. Fused ring derivatives and their pharmaceutical applications. Patent WO2021233302A1. |
Cap-dependent endonuclease-IN-21
CAS: 2741952-35-0 F: C26H23F2N3O7 W: 527.47
Cap-dependent endonuclease-IN-21 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-I
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.